X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9270) 9270
Publication (1195) 1195
Newsletter (230) 230
Book Review (134) 134
Book Chapter (78) 78
Newspaper Article (24) 24
Conference Proceeding (17) 17
Magazine Article (13) 13
Dissertation (12) 12
Book / eBook (11) 11
Reference (7) 7
Transcript (4) 4
Government Document (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Paper (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5053) 5053
animals (4933) 4933
glutamate (4762) 4762
humans (4121) 4121
male (3899) 3899
neurosciences (3078) 3078
rats (2391) 2391
female (2335) 2335
pharmacology & pharmacy (1898) 1898
mice (1358) 1358
analysis (1233) 1233
adult (1152) 1152
brain (1110) 1110
middle aged (1094) 1094
psychiatry (984) 984
rats, sprague-dawley (956) 956
disease models, animal (880) 880
clinical neurology (870) 870
neurons (842) 842
article (840) 840
dose-response relationship, drug (806) 806
aged (784) 784
oxidative stress (775) 775
physiological aspects (765) 765
biochemistry & molecular biology (753) 753
neurology (747) 747
gaba (738) 738
research (716) 716
amino acids (705) 705
rats, wistar (692) 692
glutamic acid - metabolism (683) 683
oncology (661) 661
guanine - analogs & derivatives (648) 648
pemetrexed (644) 644
treatment outcome (642) 642
schizophrenia (616) 616
methyl aspartate (606) 606
time factors (555) 555
health aspects (536) 536
care and treatment (526) 526
rodents (512) 512
neurons - drug effects (511) 511
expression (510) 510
brain - metabolism (503) 503
toxicology (497) 497
glutamates - administration & dosage (493) 493
glutamates - adverse effects (484) 484
hippocampus (483) 483
brain - drug effects (469) 469
proteins (456) 456
dopamine (453) 453
epilepsy (450) 450
guanine - administration & dosage (432) 432
metabolism (432) 432
excitatory amino acid antagonists - pharmacology (429) 429
biomedicine (425) 425
rat (417) 417
cell biology (411) 411
chemotherapy (400) 400
neuroprotection (400) 400
drug therapy (398) 398
cells, cultured (395) 395
lung neoplasms - drug therapy (389) 389
neurons - metabolism (385) 385
glutamate receptors (376) 376
apoptosis (373) 373
cancer (369) 369
double-blind (366) 366
gene expression (364) 364
nervous system (358) 358
seizures (354) 354
metabotropic glutamate receptors (351) 351
monosodium glutamate (350) 350
mice, inbred c57bl (348) 348
double-blind method (347) 347
guanine - adverse effects (344) 344
long-term potentiation (343) 343
medicine (343) 343
carcinoma, non-small-cell lung - drug therapy (341) 341
neurotoxicity (338) 338
nmda receptor (336) 336
antineoplastic combined chemotherapy protocols - therapeutic use (334) 334
receptors, n-methyl-d-aspartate - metabolism (333) 333
in-vivo (331) 331
enzymes (330) 330
prefrontal cortex (327) 327
endocrinology & metabolism (324) 324
receptors, n-methyl-d-aspartate - antagonists & inhibitors (322) 322
hippocampus - drug effects (320) 320
medicine & public health (320) 320
neuroprotective agents - pharmacology (318) 318
clinical trials (317) 317
glutamates - therapeutic use (315) 315
research article (314) 314
receptors (313) 313
pregnancy (312) 312
central-nervous-system (311) 311
synaptic plasticity (309) 309
adolescent (308) 308
pharmacology (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9431) 9431
Japanese (37) 37
German (36) 36
French (26) 26
Chinese (24) 24
Russian (23) 23
Spanish (19) 19
Italian (10) 10
Ukrainian (4) 4
Turkish (3) 3
Croatian (2) 2
Norwegian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 10/2018, Volume 141, pp. 214 - 222
Journal Article
STEM CELLS, ISSN 1066-5099, 10/2009, Volume 27, Issue 10, pp. 2591 - 2601
Journal Article
Journal Article
Experimental and Toxicologic Pathology, ISSN 0940-2993, 09/2017, Volume 69, Issue 7, pp. 547 - 556
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
In a prospective, randomized, phase 3 trial of crizotinib as second-line therapy in patients who had disease progression while receiving a platinum-based... 
REARRANGEMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | ONCOLOGY | EML4-ALK FUSION GENE | CLINICAL-TRIALS | PHASE-III | LYMPHOMA | OPEN-LABEL | DOCETAXEL | EGFR | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Lymphomas | Respiration | Pharmaceutical industry | Protein-tyrosine kinase
Journal Article